Genmab Expands use of IDBS’ ActivityBase Xtended Edition in Hybridoma Discovery

News   Sep 12, 2007

 
Genmab Expands use of IDBS’ ActivityBase Xtended Edition in Hybridoma Discovery
 
 
 

RELATED ARTICLES

Concept Life Sciences appoints New Group Programme Manager and US Head of Sales

News

Key leadership appointments support integration of the Group and expansion in the US market.

READ MORE

Metrohm USA Opens Its New Headquarters in Florida

News

Metrohm USA welcomes its Tampa employees to their new North American headquarters in Riverview, Florida.

READ MORE

Blood-vessel-on-a-chip Provides Insight into Novel Anti-Inflammatory Drug Candidate

News

Researchers have discovered that synthetic APC-mimicking small molecules called “parmodulins” provide anti-inflammatory and anti-thrombotic protection to endothelial cells on par with APC’s without interfering with normal blood clotting and coagulation, making them attractive new drug candidates.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE